Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Preferred Stock Liabilities (2020 - 2021)

Agilon Health's Preferred Stock Liabilities history spans 2 years, with the latest figure at $309.5 million for Q1 2021.

  • For Q1 2021, Preferred Stock Liabilities changed 0.0% year-over-year to $309.5 million; the TTM value through Mar 2021 reached $309.5 million, changed 0.0%, while the annual FY2020 figure was $309.5 million, 10.14% up from the prior year.
  • Preferred Stock Liabilities reached $309.5 million in Q1 2021 per AGL's latest filing, roughly flat from $309.5 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $309.5 million in Q1 2020 to a low of $309.5 million in Q1 2020.